Israel Englander’s KALA BIO KALA Stock Holding History

Israel Englander’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-16	Closed	-$410K	–	4644
2020 Q2	$410K	Buy	+16	New	+$453K	﹤0.01%	3520

Other funds holding KALA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Israel Englander's KALA Position: Q1 2025 in Review

Israel Englander sold out of KALA BIO (KALA) in Q1 2025, closing a stake of 2,721 shares — an estimated $944K sold.

Israel Englander first reported a position in KALA in Q3 2017 and held it in 30 quarters. The position peaked at $15.8M in Q1 2018. 25 funds tracked by Wall St. Rank hold KALA as of Q1 2025.

Israel Englander reported no remaining KALA BIO position as of Q1 2025 after selling out during the quarter.
Israel Englander sold 2,721 KALA BIO shares in Q1 2025, an estimated $944K.
Israel Englander first reported a position in KALA BIO in Q3 2017 and held it in 30 quarters.
Israel Englander's KALA BIO position peaked at $15.8M in Q1 2018.
25 funds tracked by Wall St. Rank held KALA BIO as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.